Zobrazeno 1 - 10
of 49
pro vyhledávání: '"Mark, Levenson"'
Autor:
Mark Levenson, Weili He, Li Chen, Sai Dharmarajan, Rima Izem, Zhaoling Meng, Herbert Pang, Frank Rockhold
Publikováno v:
Statistics in Biopharmaceutical Research. :1-8
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4a5581cd9e0e3ec9a05cf25511477de4
https://doi.org/10.1080/19466315.2022.2120533
https://doi.org/10.1080/19466315.2022.2120533
Autor:
Di Zhang, Jaejoon Song, Sai Dharmarajan, Tae Hyun Jung, Hana Lee, Yong Ma, Rongmei Zhang, Mark Levenson
Publikováno v:
Statistics in Biopharmaceutical Research. :1-5
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a918d6d850e7e9ba3cc0724ab049c8ea
https://doi.org/10.1080/19466315.2022.2108135
https://doi.org/10.1080/19466315.2022.2108135
Autor:
Frank W. Rockhold, Richard C. Zink, Yixin Fang, JC Chen, Pallavi Mishra-Kalyani, Weili He, Martin Ho, Douglas E. Faries, Kwan Lee, Benjamin A. Goldstein, Hong-Wei Wang, Mark Levenson
Publikováno v:
Statistics in Biopharmaceutical Research. 15:3-13
Real-world evidence (RWE), derived from data from “real-world” clinical practice and medical product utilization, is an increasingly important source of evidence that holds great potential to incre...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1c38f0856cd64373a6823793cdf4d7b1
https://doi.org/10.1080/19466315.2021.1883473
https://doi.org/10.1080/19466315.2021.1883473
Autor:
Steve Zeliadt, Richard Platt, Denise Esserman, Matthew T. Roe, Mark Levenson, Benjamin A. Goldstein
Publikováno v:
Clinical Trials. 17:405-413
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ebc86909d7d11e6fc1d15f7fa154f57f
https://doi.org/10.1177/1740774520928607
https://doi.org/10.1177/1740774520928607
Publikováno v:
JAMA neurology. 79(3)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d17e288643ab2c5c1955b2a19349ac59
https://pubmed.ncbi.nlm.nih.gov/35099505
https://pubmed.ncbi.nlm.nih.gov/35099505
Autor:
Mark Levenson, Weili He
Publikováno v:
Statistics in Biopharmaceutical Research. 15:27-28
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bc3f0f0a0c636a2010eb319f4850f809
https://doi.org/10.1080/19466315.2022.2090430
https://doi.org/10.1080/19466315.2022.2090430
Autor:
Sean D. Pokorney, Noelle Cocoros, Hussein R. Al-Khalidi, Kevin Haynes, Shuang Li, Sana M. Al-Khatib, Jacqueline Corrigan-Curay, Meighan Rogers Driscoll, Crystal Garcia, Sara B. Calvert, Thomas Harkins, Robert Jin, Daniel Knecht, Mark Levenson, Nancy D. Lin, David Martin, Debbe McCall, Cheryl McMahill-Walraven, Vinit Nair, Lauren Parlett, Andrew Petrone, Robert Temple, Rongmei Zhang, Yunping Zhou, Richard Platt, Christopher B. Granger
Publikováno v:
JAMA Network Open. 5:e2214321
Only about half of patients with atrial fibrillation (AF) who are at increased risk for stroke are treated with an oral anticoagulant (OAC), despite guideline recommendations for their use. Educating patients with AF about prevention of stroke with O
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6eb82e74dfd0dbce53e72881aaba679
https://doi.org/10.1001/jamanetworkopen.2022.14321
https://doi.org/10.1001/jamanetworkopen.2022.14321
Autor:
Mark Levenson, Sylva H. Collins
Publikováno v:
Statistics in Biopharmaceutical Research
article-version (VoR) Version of Record
article-version (VoR) Version of Record
COVID-19 has imposed significant difficulties in the conduct and analysis of clinical trials. The full extent of the consequence of COVID-19 will not be known for some time. Nonetheless, the impact...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4ab916f9f3e29ef3b291de9394d8caf
Autor:
Mark Levenson
Publikováno v:
Clin Trials
Real-world data and evidence provide the potential to address the effectiveness and safety of drugs. The U.S. Food & Drug Administration has initiated a program to evaluate the potential use of real-world evidence for regulatory uses. Whether a study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f7971b4bd76bf57a7239068cc551684a
https://europepmc.org/articles/PMC8697198/
https://europepmc.org/articles/PMC8697198/
Autor:
Haijun Ma, Soomin Park, Cyrus R. Mehta, Richard C. Zink, Jeff Maca, Chunlei Ke, Qi Jiang, Christy Chuang-Stein, Matilde Sanchez-Kam, Olga Marchenko, Estelle Russek-Cohen, Mark Levenson, Lingyun Liu
Publikováno v:
Statistics in Biopharmaceutical Research. 9:347-360
This is the second article written by the American Statistical Association Biopharmaceutical Section Safety Working Group. In the first article, we reviewed the drugs approved by the United States Food and Drug Administration to treat type 2 diabetes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b320080bd714c1ff9a578e69e30cb1cf
https://doi.org/10.1080/19466315.2017.1280411
https://doi.org/10.1080/19466315.2017.1280411